Scaffolds, Stem Cells, and Tissues. Oh, My!
A primer for how the FDA regulates stem cells
A primer for how the FDA regulates stem cells
Johnny Franco, MD, FACS, discusses how implant removals, biologic innovation, and patient demand for long-term tissue health are accelerating a regenerative shift in body aesthetics.
A noninvasive molecular test identifies patients more likely to respond to JAK inhibitors versus Th2-targeted therapies, potentially accelerating clearance and reducing treatment switches.